(2E)-N-(3,4-DIHYDRO-4-OXO-7-(((3S)-TETRAHYDRO-3-FURANYL)OXY)-6-QUINAZOLINYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE
UNII 8P652B3QLZ
Substance Identification & Data
This profile provides standardized clinical and technical data for (2e)-n-(3,4-dihydro-4-oxo-7-(((3s)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-2-butenamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8P652B3QLZ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1456696-14-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H22N4O4 GSUSIQVMAQBROU-PCAWENJQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2e)-n-(3,4-dihydro-4-oxo-7-(((3s)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-2-butenamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.